Recent cases involve charges and judgments related to COVID-19 add-on tests, genetic testing fraud, and kickbacks.
A strategic partnership with Google enables more accurate whole genome sequencing with machine learning.
New ACMG recommendations aim to make CFTR carrier detection more equitable among a wider range of ancestries.
Inadequate CMS oversight resulted in $888.2 million in improper payments for the highest reimbursing molecular pathology genetic tests, report says.
Release of second-generation Cologuard test data and recently announced partnerships aim to position company well for the future.